Companies · Healthtech

Adigica Health, Inc.

SAN DIEGO · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Adigica Health, Inc. — recommendation, valuation, rhythm, risks.
$21.8M
Total raised · real
5
Rounds
2.3×
Latest step-up
Top 20%
Sector rank · raised
Series A
Latest stage · inferred · Wed Feb 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Adigica Health, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.16× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.4 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Adigica Health, Inc. is one of 2138 Healthtech companies tracked from SAN DIEGO. By capital raised it ranks in the upper tier (ahead of 81% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
13
Investors (latest)
2021-02-17
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeed · 2016-02-29 Raised $1.6M (real) Modeled valuation $45M (est)$1.6M$45MSeed2016Series A · 2019-01-23 Raised $11M (real) Modeled valuation $253M (est)$11M$253MSeries A2019Series A · 2019-01-23 Raised $7.5M (real) Modeled valuation $170M (est)$7.5M$170MSeries A2019Series A · 2020-10-19 Raised $450K (real) Modeled valuation $9.1M (est)$450K$9.1MSeries A2020Series A · 2021-02-17 Raised $1.0M (real) Modeled valuation $18M (est)$1.0M$18MSeries A2021+$11M+$7.5M+$450K+$1.0MCumulative $22M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.6M · 2016
Series A$11.2M · 2019
Series A extension$7.5M · 2019
Series A extension$450K · 2020
Series A extension$1.0M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$18.2M
Base estimate est.
$1.3M
Conservative case
$85.8M
Upside case
$4.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $44.5M · 2016-02-292016Series A · modeled $252.8M · 2019-01-23Series A · modeled $169.5M · 2019-01-23Series A · modeled $9.1M · 2020-10-19Series A · modeled $18.2M · 2021-02-172021
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.46×/yr
Annual markup
1.84×/yr upside case
5.4 yr
Elapsed time used
5.4 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
15 mo
Avg between rounds
$4.4M/yr
Capital velocity
10.3 yr
On record since
2016
First round
5
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.9× above median
This company$21.8M
Sector median$4.5M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$1.0M
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 0.5× of median
This company$18.2M
Sector median$33.8M

Raised more than 81% of sector peers (real $). Modeled value above 43% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #117 of 124.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)Itamar Medical Ltd. · Series A Raised $14.7M · modeled $331.4M (est)ChartSpan Medical Technologies, Inc. · Series A Raised $14.7M · modeled $330.7M (est)4G Clinical, LLC · Series A Raised $24.3M · modeled $330.0M (est)Wellness Group Investors, LLC · Series A Raised $14.0M · modeled $294.5M (est)Avation Medical, Inc. · Series A Raised $12.9M · modeled $291.8M (est)Fresenius Medical Care Baldwin County, LLC · Series A Raised $12.8M · modeled $289.6M (est)Blue Ox Healthcare Partners SP, LLC · Series A Raised $12.6M · modeled $284.7M (est)LIBERTY DENTAL PLAN Corp · Series A Raised $11.8M · modeled $266.3M (est)Decisio Health, Inc. · Series A Raised $14.6M · modeled $264.3M (est)emPower Health Equity, Inc. · Series A Raised $11.2M · modeled $253.4M (est)Insightin Health Inc · Series A Raised $12.4M · modeled $234.7M (est)Edifice Health, Inc. · Series A Raised $13.8M · modeled $233.8M (est)Adigica Health, Inc. (this company) Raised $21.8M · modeled $18.2M (est)Adigica Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Itamar Medical Ltd.Series A$14.7M$331.4M2.83×
ChartSpan Medical Technologies, Inc.Series A$14.7M$330.7M2.82×
4G Clinical, LLCSeries A$24.3M$330.0M2.82×
Wellness Group Investors, LLCSeries A$14.0M$294.5M2.51×
Avation Medical, Inc.Series A$12.9M$291.8M2.49×
Fresenius Medical Care Baldwin County, LLCSeries A$12.8M$289.6M2.47×
Blue Ox Healthcare Partners SP, LLCSeries A$12.6M$284.7M2.43×
LIBERTY DENTAL PLAN CorpSeries A$11.8M$266.3M2.27×
Decisio Health, Inc.Series A$14.6M$264.3M2.26×
emPower Health Equity, Inc.Series A$11.2M$253.4M2.16×
Insightin Health IncSeries A$12.4M$234.7M2.00×
Edifice Health, Inc.Series A$13.8M$233.8M2.00×
Adigica Health, Inc. this companySeries A$21.8M$18.2M0.16×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.6M2016-02-29$8.0M$44.5M85%
Series A$11.2M2019-01-23$50.9M$252.8M90%
Series A$7.5M2019-01-23$34.1M$169.5M90%
Series A$450K2020-10-19$2.0M$9.1M90%
Series A$1.0M2021-02-17$4.7M$18.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.6M2016-02-29
    • First recorded raise — entered as Seed.
    • 10 investors on this round.
  2. Series A$11.2M2019-01-23
    • Raised again after 35 mo — slower than the ~14 mo sector norm.
    • Round 7.0× larger than the prior — scaling up.
    • 22 investors on this round.
  3. Series A$7.5M2019-01-23
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 40 investors on this round.
  4. Series A$450K2020-10-19
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 16.7× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  5. Series A$1.0M2021-02-17
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
    • 13 investors on this round.
Intelligence
2022 ~Q2
Modeled next raise · ~15mo cadence
$2.3M
Modeled next size est.range $1.5M$3.7M
2.3×
Last step-up
$4.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David F Hale15 other2016-02
Cam L. Garner10 other2016-02
Kathleen D. Scott4 other2016-02
Brandon Fishman2020-10
Frederick F. Sliter, III2020-10
Frederick G. Sliter III2016-02
Howard F. Palefsky2016-02
Ilya G. Nykin2019-01
Robert G. Rosenberg2019-01
Stephen Cushman2020-10
Tracy F. Julien2020-10
William F. Strauss2016-02
Registry & provenance

Adigica Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1682256
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Recros Medica, Inc.BiotechnologySeries A$9.9M$149.0Mnetwork2 shared operators · same stage
Olio Health, Inc.HealthtechSeries A$22.3M$22.0Msame sector · same stage
Minnesota Medical Technologies CorpHealthtechSeries A$20.7M$24.2Msame sector · same stage
Redi.Health Inc.HealthtechSeries A$23.0M$19.9Msame sector · same stage
Reperio Health, Inc.HealthtechSeries A$23.4M$26.6Msame sector · same stage
Levee Medical, Inc.HealthtechSeries A$20.3M$13.5Msame sector · same stage
Odyssey Wellness LLCHealthtechSeries A$25.0M$14.5Msame sector · same stage
Youme Healthcare, Inc.HealthtechSeries A$18.8M$9.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Navinata Health, Inc.HealthtechPre-Seed$19.7M88%
NeuSpera Medical Inc.HealthtechSeries C$1.3B85%
Oncora Medical, Inc.HealthtechSeed$52.5M85%
Solera Health, Inc.HealthtechSeries B$935.6M85%
Silna Health, Inc.HealthtechSeries A$34.3M85%
Sana Health, Inc.HealthtechSeries A$128.9M85%
Covera Health, Inc.HealthtechSeries B$485.3M84%
Sansoro Health, Inc.HealthtechSeries A$118.5M84%
Frequently asked
How much funding has Adigica Health, Inc. raised?
Adigica Health, Inc. has raised approximately $21.8M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Adigica Health, Inc.'s estimated valuation?
Provath's modeled valuation for Adigica Health, Inc. is approximately $18.2M (modeled range $1.3M–$85.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Adigica Health, Inc. at?
Adigica Health, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Feb 17.
What does Adigica Health, Inc. do and where is it based?
Adigica Health, Inc. operates in the Healthtech sector, based in SAN DIEGO.
Explore related

See where Adigica Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Adigica Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.